Are thiazide diuretics preferred as first-line therapy for hypertension? An appraisal of The Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
- 1 July 2003
- journal article
- clinical trial
- Published by Wiley in Internal Medicine Journal
- Vol. 33 (7), 327-330
- https://doi.org/10.1046/j.1445-5994.2003.00431.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A Comparison of Outcomes with Angiotensin-Converting–Enzyme Inhibitors and Diuretics for Hypertension in the ElderlyNew England Journal of Medicine, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Jama-Journal Of The American Medical Association, 2002
- Hypokalemia Associated With Diuretic Use and Cardiovascular Events in the Systolic Hypertension in the Elderly ProgramHypertension, 2000
- Salt Sensitivity of Blood Pressure in HumansHypertension, 1996
- Comparative effects of diltiazem and hydrochlorothiazide in blacks with systemic hypertensionThe American Journal of Cardiology, 1985
- Efficacy of Nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertensionThe American Journal of Cardiology, 1983